Shorter vs fewer radiation sessions for breast cancer
Part of Cancer clinical trials.
This trial compares two types of partial breast radiation: one session versus several shorter sessions. It aims to see if a single treatment is as effective and more convenient for women with early-stage breast cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 40 or older.
- You have early-stage breast cancer (stage 0 to 2) with a tumor smaller than 3 cm and no spread to lymph nodes or other organs.
- You are able to lie still and tolerate the radiation treatment position.
- You have not had radiation to the same breast area before.
- You are not pregnant or breastfeeding.
- You do not have a known BRCA1 or BRCA2 gene mutation.
- You do not have serious medical conditions that might make radiation unsafe (e.g., lupus or scleroderma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of radiation therapy for early-stage breast cancer after lumpectomy: radiation to just the part of the breast where the cancer was removed (partial breast) versus radiation to the whole breast. The goal is to see if partial breast radiation works just as well, with fewer side effects and a shorter treatment time.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial compares a one-week radiation treatment to a three-week treatment for early-stage breast cancer. It aims to see if the shorter course is as effective and safe, potentially making treatment more convenient.
This trial compares a shorter course of radiation focused on part of the breast versus a standard approach after lumpectomy. It aims to see if treating a smaller area can control the cancer while reducing treatment burden.
This trial tests whether radiation therapy alone is safe and effective for women 40 and older with early-stage breast cancer who have not had lymph node sampling. It aims to simplify treatment while maintaining good outcomes.
This trial tests a shorter course of radiation to only the part of the breast where cancer has come back. It's for women who had radiation years ago and now have a small new or recurrent tumor that can be removed by surgery.
Hear when a new Breast Cancer Early Stage Breast Cancer (Stage 1-3) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.